WebMar 10, 2024 · The males carry a protein that causes any females born to die ... The male insects have been genetically modified to express the protein tTAV-OX5034, which results in the death of any newly ... WebMar 15, 2024 · Footnote 10 Specifically for Oxitec's OX5034 Aedes aegypti, the tetracycline-repressible transactivator protein variant (tTAV-OX5034), which prevents female offspring from surviving, was recognized as the active ingredient, while the DsRed2-OX5034 marker protein was identified as an inert ingredient.
OFFICE OF CHEMICAL SAFETY AND POLLUTION …
WebAug 31, 2024 · The DNA sequence of tTAV -OX5034 contains additional features (relative to OX513A) that enable its expression only in female mosquitoes, but the protein sequence … WebDec 14, 2010 · Tetracycline-controlled transactivator (tTAV) is a synthetic protein coding sequence based on a fusion of sequences from Escherichia coli and Herpes simplex … dealing with night terrors
BCH-LMO-SCBD-115346 - The Biosafety Clearing-House (BCH)
WebJun 9, 2024 · tTAV–OX5034 protein on 6,600 acres to evaluate the control of Aedes aegypti mosquitoes. The program is authorized only in the States of Florida and Texas. The EUP is effective from April 30, 2024 to April 30, 2024. Authority: 7 U.S.C. 136 et seq. Dated: May 27, 2024. Robert McNally, Director, Biopesticides and Pollution WebJun 9, 2024 · 93167-EUP-2. Issuance. Oxitec, Ltd., c/o Wiley Rein 1776 K Street NW, Washington, DC 20006. This EUP allows the use of 0.0115 pounds (5193.56 mg) of the … WebThis precludes positive feedback and only the benign, basal level of tTAV, is produced. The second component is a gene that encodes for a fluorescent protein (DsRed2). DsRed2 … general nathan f twining